| 000 | 01466 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517033320.0 | ||
| 264 | 0 | _c20160913 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.13922 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFabiano, A | |
| 245 | 0 | 0 |
_aEruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with ruxolitinib. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cOct 2015 |
||
| 300 |
_a1098-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xchemically induced |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratoacanthoma _xchemically induced |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPyrazoles _xadverse effects |
| 650 | 0 | 4 | _aPyrimidines |
| 650 | 0 | 4 |
_aSkin Neoplasms _xchemically induced |
| 700 | 1 | _aCalzavara-Pinton, P | |
| 700 | 1 | _aMonari, P | |
| 700 | 1 | _aMoggio, E | |
| 700 | 1 | _aPellacani, G | |
| 700 | 1 | _aManganoni, A M | |
| 700 | 1 | _aGualdi, G | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 173 _gno. 4 _gp. 1098-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.13922 _zAvailable from publisher's website |
| 999 |
_c24923121 _d24923121 |
||